Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with ...
BioSkryb Genomics and Tecan report that they have introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ whole genome and transcriptome single-cell ...
TXG stock jumps after unveiling Atera, a next-gen spatial biology platform aiming to scale single-cell analysis and deepen its role in drug discovery and research.
26d
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 ...
Live-cell analysis advance: A new technique enables repeated, non-destructive transcriptome measurements, supporting long-term biomedical research. Critical Ivanti vulnerability: Ivanti patched an ...
BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME ™ Whole Genome and Transcriptome Single-Cell Core Kit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results